U
GrantUnlock
Science & Technology

NanoDiscs for Immune Modulation in Celiac Disease

Department of Health and Human Services — National Institutes of Health

Opportunity #: 1R44AI192013-01

Award Ceiling
$1.1M
Award Floor
$1.1M
Close Date
Aug 31, 2027
534 days left
Total Funding
$1.1M
Expected Awards
1
Posted Date
Sep 19, 2025
Cost Sharing Required
No
Grants.gov ID
sbir-1R44AI192013-01

Description

SBIR Phase Phase II award: "NanoDiscs for Immune Modulation in Celiac Disease" awarded to EVOQ THERAPEUTICS, INC. in ANN ARBOR, Michigan. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $1,050,000. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.

Eligible Applicants

Small businesses

Apply on Grants.gov

Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.

View on Grants.gov
Disclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.